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Abstract: Parenteral routes of drug administration are often selected to optimize actual dose of
drug delivered, assure high bioavailability, bypass first-pass metabolism or harsh gastrointestinal
environments, as well as maximize the speed of onset. Intramuscular (IM) delivery can be preferred to intravenous delivery when initiating intravenous access is difficult or impossible. Drugs
can be injected intramuscularly using a syringe or an automated delivery device (autoinjector).
Investigation into the IM delivery dynamics of these methods may guide further improvements in
the performance of injection technologies. Two porcine model studies were conducted to compare
differences in dispersion of injectate volume for different methods of IM drug administration. The
first study compared the differences in the degree of dispersion and uptake of injectate following
the use of a manual syringe and an autoinjector. The second study compared the spatial spread
of the injected formulation, or dispersion volume, and uptake of injectate following the use of
five different autoinjectors (EpiPen® [0.3 mL], EpiPen® Jr [0.3 mL], Twinject® [0.15 mL, 0.3
mL], and Anapen® 300 [0.3 mL]) with varying needle length, needle gauge, and force applied
to the plunger. In the first study, the autoinjector provided higher peak volumes of injectate,
indicating a greater degree of dispersion, compared with manual syringe delivery. In the second
study, EpiPen autoinjectors resulted in larger dispersion volumes and higher initial dispersion
ratios, which decreased rapidly over time, suggesting a greater rate of uptake of injectate than
the other autoinjectors. The differences in dispersion and uptake of injectate are likely the result
of different functional characteristics of the delivery systems. Both studies demonstrate that
the functional characteristics of the method for delivering IM injections impact the dispersion
and uptake of the material injected, which could significantly affect the pharmacokinetics and,
ultimately, the effectiveness of the drug.
Keywords: anaphylaxis, autoinjector device, injector pen, intramuscular drug administration,
dispersion volume
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The key to treating medical emergencies such as anaphylaxis and prolonged seizures is
rapid administration of the appropriate medications.1,2 Delayed treatment is associated
with poorer outcomes.3–5 One important variable affecting time to treatment is the route
of drug administration. The onset of action with oral administration is inherently slow
and therefore not suitable for patients experiencing a medical emergency. Other routes of
administration (ie, rectal, intranasal, transdermal, and sublingual) may be inconvenient,
difficult for administration, or physiologically and/or pharmacologically impractical.6–8
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Parenteral drug therapy usually provides a more rapid
uptake of drug and is therefore preferred over oral therapy,
when available. Among the possible parenteral routes, the
subcutaneous route generally has the longest time to effect
and is the simplest to administer. The intravenous (IV) route
has the most rapid onset of action but IV access can be difficult, time-consuming, and sometimes impossible to achieve.
The intramuscular (IM) route provides a compromise, since
it often results in an intermediate time to onset of action and
can often be accomplished without difficulty. IM administration of benzodiazepines via an autoinjector has been shown
to be at least as safe and effective as the IV route for treating
prolonged convulsive seizures in the prehospital setting.9 An
additional advantage of IM drug administration is that it may
provide greater consistency in absorption than subcutaneous
administration.10–12
There are several methods for delivering drugs by the IM
route, and recent advances in IM drug transport dynamics13
may guide further improvements to the performance of current and alternative injection technologies. To best evaluate
the growing variety of methodologies and their unique
design characteristics, it is important to develop experimental
models that provide a means to evaluate various devices
with respect to discrete properties of the IM injection. Our
studies build on the work of Wu et al13 which documented the
mechanical influences of active tissue on drug permeability
and transport by using isolated muscle model systems. In this
study, we developed an animal model that has the advantages
of muscle mass parameters close to human skeletal muscle
and nonischemic, living tissue. A computed tomography (CT)
imaging technique was used to measure the dispersion and
uptake of the injectate. CT image analysis provided a means
to evaluate the influence of device parameters, such as needle
length, needle gauge, injection volume, and plunger force (ie,
speed and pressure of delivery provided either manually or by
a spring), on specific aspects of IM injection that ultimately
affect drug pharmacokinetics and effectiveness.
A manual syringe requires that the user applies a force
sufficient to deliver the drug. The extent of this force is
dependent on a number of parameters including user dexterity, fluid viscosity, needle length and gauge, friction between
the syringe plunger and syringe barrel, cross-sectional area
of the syringe plunger, and plunger displacement.14 An autoinjector provides a consistent spring force profile to push the
drug out of the syringe. The internal spring is compressed
prior to activation and is released either by a button press or
by applying pressure to the needle end of the autoinjector,
depending on the design. The spring force is designed to be
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sufficient to deliver the drug, which is affected by the same
parameters as for the manual syringe.
Two studies using our animal model and imaging
technique were conducted separately to compare different
devices used to deliver an IM drug administration. The
first study compared the use of a manual syringe and an
autoinjector, and, for each method, assessed whether needle
length and gauge were related to injectate dispersion volume
(spatial spread of injectate) and uptake (reduction in injectate
volume in tissue). The second study compared the impact
of five different autoinjectors with varying needle length,
needle gauge, and spring force on the dispersion volume
and uptake of injectate.

Materials and methods
Study 1: autoinjector versus manual
syringe
The dispersion volumes of the injectate from an autoinjector (Diazepam Auto-Injector; Pfizer Inc., New York, NY,
USA)10,15 were compared with that of a manual syringe
(Monoject™ 3 mL syringe; Covidien, Mansfield, MA, USA)
using CT imaging in a pig animal model. The study was
conducted according to US Food and Drug Administration
Good Laboratory Practice for Nonclinical Studies16 in the
Department of Radiology at Georgetown University between
March 18, 2006, and April 29, 2006, under an Institutional
Animal Care and Use Committee-approved animal care and
use protocol (#05-021).

Pigs
Nine female Yorkshire pigs were purchased from Thomas D
Morris, Inc. (Reisterstown, MD, USA). Animals were identified by the vendor using permanent ear tags. Animals were
acclimated 3–4 days prior to each investigation. All animals
were examined upon arrival, housed in a controlled environment, and fed Purina™ Lab Diet 5084 (Purina Lab Diet, St
Louis, MO, USA, noncertified) with tap water provided by
an automatic water system, available ad libitum from the
day of arrival to the end of study. A total of eight animals
(one animal died due to anesthetic complications prior to
injection) were randomized by random card draw and were
studied in two groups of four animals each (groups P1 and
P2, Table 1).

Injection devices and injectate
The investigation was conducted using eight autoinjectors
and eight manual syringes. The Diazepam Auto-Injector
(Pfizer Inc.) was a cylindrically shaped, pressure-activated,
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Table 1 Study details
Study group (n=4/group)

Needle gauge (Ga) × length (in)

Study 1: Diazepam Auto-Injector versus Monoject™ manual syringe
P1
22×0.6 autoinjector versus 22×0.6 syringe
P2
20×0.8 autoinjector versus 20×0.8 syringe
Study group (n=4/group)

Autoinjector comparison

Administration

Evaluation

Autoinjector in left thigh,
manual syringe in right thigh

Dispersion and uptake of injectate

Administration

Evaluation

Study 2: Anapen® and Twinject® autoinjectors versus EpiPen® autoinjector
P1
Anapen 0.3 mL versus EpiPen 0.3 mL
Each animal was injected with
EpiPen in the left thigh and test
P2
Twinject 0.15 mL versus EpiPen® Jr 0.3 mL
injector in the right thigh
P3
Twinject 0.3 mL versus EpiPen 0.3 mL

prefilled 3 mL automatic syringe delivery device. One
version contained a 22 gauge ×0.6 inch (22 Ga ×0.6 in
[length of needle extended from the device]) needle and
the other contained a 20 Ga ×0.8 in needle. Two versions
of the manual (Monoject™, Covidien) 3 mL syringes were
also used in the study: one with a 22 Ga ×1.5 in needle and
one with a 20 Ga ×1.5 in needle. A needle depth marker
(Cook Inc., Bloomington, IN, USA) was manually placed
and secured onto each Monoject™ needle (Covidien) so
that the maximum IM penetration of the 22 Ga needle was
0.6 in and the maximum penetration of the 20 Ga needle was
0.8 in to ensure direct comparability to the autoinjectors. The
measurement from the tip of the needle to the proximal edge
of the needle depth marker was assessed with digital calipers
(VWR, Clarksburg, MD, USA).
The injectate used in both the autoinjector and the standard
syringe was a solution containing 0.25 mL per mL Omnipaque
300™ (Amersham Health Inc., Princeton, NJ, USA) combined with 0.75 mL per mL of a solution made using the
following formula (per mL solution): 447.50 mg propylene
glycol USP, 94.50 mg ethanol (95%) USP, 17 mg benzyl
alcohol NF, 45.50 mg sodium benzoate NF, 3.75 mg benzoic
acid USP, and a sufficient quantity of purified water to bring
solution to 1 mL. Both autoinjectors and syringes were prefilled with 2 mL of injectate.

Study 1 procedure
Animals were weighed and anesthetized in the Division of
Comparative Medicine (Georgetown University) on the day
of testing. Anesthesia was induced by the administration of
IM ketamine/xylazine given in the lateral neck muscles or
rear leg and IV atropine and thiopental given via an ear vein
catheter. The animals were intubated, ventilated, and placed
on isoflurane gas (1%–3%) to maintain anesthesia. During
transport and throughout the study, the pigs were placed on
their backs on a V-trough and oriented on the CT table with
the head toward the front of the gantry. Anesthetized pigs
received two simultaneous IM injections of 2 mL injectate.
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Two technicians performed the injections: one administered
the injectate with the manual syringe (right thigh) and the
other used the autoinjector (left thigh). To identify equivalent
injection sites on each thigh, each target was found by
palpating the patella and then measuring 3 cm medially or
laterally from the patella into the muscle mass and marked
with indelible ink prior to the injection.
Tissue at each of the marked sites was pinched and rotated
to allow better access to the designated muscle belly, and
either the autoinjector or syringe was applied and deployed.
Autoinjectors and syringes were held in place for 5 seconds
after completing the injection. Following the injection, the
length of the manual syringe needle was remeasured using
the digital calipers to evaluate whether or not the needle
depth marker had shifted.
The first group (P1) was injected with the 22 Ga needles
of the manual syringe and autoinjector; the second group (P2)
was injected with the 20 Ga needles of the manual syringe
and autoinjector.

CT imaging analysis
CT imaging (Somatom Volume Zoom CT Scanner with
fluoroscopy capability; Siemens, Forchheim, Germany) was
used to measure the dispersion parameters of the injectate.
An initial CT fluoroscopy image was obtained during the
injection, and then a series of CT volumes was obtained
following completion of injection. The first of these CT
volumes was obtained approximately 10 seconds from the
time of injection to the first scan. Subsequent CT volumes
were then obtained at 1, 5, 10, 15, 20, 30, 45, and 60 minutes
after injection. The CT images were acquired using 165 mAs
at 120 kV with a rotation time of 0.5 seconds. Narrow collimation (1.0 mm) was used with a 3.0 mm slice width and
a rotation/table feed of 5.0 mm.14 A medium smooth reconstruction kernel (B30f) and a reconstruction increment of
1.0 mm were used.
CT image analysis was performed using the Analyze©
software (Mayo Clinic, Rochester, MN, USA). Analyze 5.0
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was used. Total volume measure (in mm3) based on voxel
signal intensity was derived for each time point using a
manual threshold technique.17 An intensity threshold that
adequately visualized injectate and bone was manually identified in the first CT scan. Scans collected at subsequent time
intervals use this same threshold to segment the CT dataset.
The injectate volume is identified through a region growing
method, seeded with manually selected points identifying
injectate site. For each segmented injectate volume, the mean
and standard deviation of voxel intensities were computed.
For each trial, a reduction in the injectate volume over time
was interpreted as representing dispersion of injectate from
tissue. The average rate of uptake of injectate was calculated
as ∆V/∆t = [(Vp - V60)/(t60 - tp)] where Vp = peak volume,
V60 = volume at 60 minutes, tp = time point of peak volume,
and t60 = 60-minute time point.
Animals were euthanized at the end of the study, following
completion of CT scans (on March 18 and March 26), using
a commercially available euthanasia solution (Euthasol™;
Virbac AH, Inc., Fort Worth, TX, USA).
A statistical analysis of the results was not performed
since the number of animals included in this study did not
support a statistical approach.

Study 2: autoinjectors with different
mechanical properties
The parameters relating to dispersion volume and uptake
were measured following injections with five autoinjectors
(EpiPen 0.3 mL and EpiPen Jr 0.3 mL [Mylan Specialty LP,
Basking Ridge, NJ, USA], Twinject 0.15 mL and Twinject 0.3
mL [Shionogi Pharma, Inc., Atlanta, GA, USA], and Anapen
300 0.3 mL [Lincoln Medical, Wiltshire, UK] autoinjectors) using CT imaging in a pig animal model. The study
was performed in the Division of Comparative Medicine at
Georgetown University on March 1, 2010 and July 24, 2010
under an Institutional Animal Care and Use Committeeapproved animal care and use protocol (#10-005).

Pigs
Thirteen female Yorkshire pigs were purchased from Thomas
D Morris, Inc. Animals were identified by the vendor using
permanent ear tags. One animal in Study 2 was used for a
prestudy procedural assessment and was euthanized on the
day after arrival and not entered into the study. This animal
was used to determine the attachment method for a denim
patch (to be injected through) and the specific location for
the injection sites to optimize the injection procedure. As in
the previous study, the remaining animals were examined
upon arrival, housed in a controlled environment, and provided with food and water as described above. A total of 12
animals were placed into three groups of four animals each
(groups P1, P2, and P3, Table 1).

Injection devices and injectate
Each study group was used to test two autoinjector devices
as follows: P1) Anapen 300, a round, prefilled, pressureactivated, automatic syringe (27 Ga ×0.3 in [length of
needle extended from the device]) intended to deliver
0.3 mL, and EpiPen, an oval, prefilled, pressure-activated,
automatic syringe (22 Ga ×0.6 in) intended to deliver
0.3 mL; P2) Twinject, a round, prefilled, automatic syringe
(25 Ga ×0.5 in needle) intended to deliver 0.15 mL and
EpiPen Jr, an oval, pressure-activated, prefilled automatic
syringe (22 Ga ×0.5 in) intended to deliver 0.3 mL; and P3)
Twinject (25 Ga ×0.5 in), as described, intended to deliver
0.3 mL, and EpiPen Jr (22 Ga ×0.5 in) as described, intended
to deliver 0.3 mL (Table 1). The functional characteristics of
each autoinjector type that could influence dispersion of the
injectate within muscle are listed in Table 2.

Study 2 procedure
Anesthesia was induced by the administration of Telazol
(Zoetis, Fort Dodge Animal Health, New York, NY, USA)
(6 mg/kg, IM), and atropine (0.5 mg/kg, IM) given in the
lateral neck muscles or rear leg. The animals had an ear

Table 2 Typical functional characteristics of autoinjectors used in Study 1 and Study 2
Diazepam 2 mL
Diazepam 2 mL
Anapen® 0.3 mL
Twinject® 0.15 mL
Twinject 0.3 mL
EpiPen® 0.3 mL
EpiPen® Jr 0.3 mL

Spring forcea (lbs)

Needle extended length (in)b

Needle gauge (Ga)

Dispense time (s)

Activation forcec (lbs)

23
23d
2.1g
6.5g
6.5g
22.7g
23.6g

0.51
0.75f
0.29g
0.48g
0.51g
0.59g
0.52g

22
20
27g
25g
25g
22g
22g

1.6
1.0f
0.78g
0.28g
0.63g
0.29g
0.30g

3.6e
4.3f
2.1g
5.6g
5.9g
6.6g
5.7g

d

e

e

Notes: aSpring force: the force applied to plunger the moment the drug is dispensed; bneedle extended length: the length of the needle that is available to enter the subject’s
thigh; cactivation force: the force required to trigger the automated injection; ddiazepam Auto-Injectors use the same spring as the EpiPen, implicating that the spring force
will be typically similar; ecertificate of Conformance for Lot RP 452-2, data from Meridian Medical Technologies; fcertificate of Conformance for Lot RP-476-B, data from
Meridian Medical Technologies; gR01-651 Functionality Report, data from Meridian Medical Technologies.
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vein catheter placed, were intubated, ventilated, and given
isoflurane (1%–3%) gas as maintenance anesthesia. The
anesthetized pigs were placed on the CT table in a V-trough
on their backs. The injection sites (one per thigh) were then
identified using digital calipers to measure 3 cm laterally
from the top of the patella. The injection site was marked
with indelible ink directly on the skin prior to injection. Both
the right and left thighs were injected simultaneously, with
different technicians performing each injection. Each autoinjector was positioned ∼90° to the injection surface. Following
activation, the autoinjectors were held in place for 5 seconds
to ensure complete delivery of the injectate.18

CT imaging analysis
CT imaging (Somatom Emotion 16 CT Scanner; Siemens)
was used to determine the injectate dispersion into the muscle
and subsequent uptake of the injectate over time. Serial CT
images were acquired as previously described for Study 1.
However, the interval between images was shorter than was
used for Study 1, as was the total time period over which the
series was collected. This change was made in order to get
a better definition of the time resolution for injectate uptake
during the earlier time points when the greatest change was
observed in Study 1. An initial scan was obtained as soon
as the technicians performing the injection left the room
(designated time zero) and then at times 1, 2, 3, 4, 5, 7, 9, 11,
13, and 15 minutes postinjection. CT images were acquired
at 110 kV with a rotation time of 0.1 seconds. Narrow collimation (1.0 mm) was used as before, with a 1.0 mm slice
width and a medium smooth reconstruction kernel (B30f),
with a reconstruction increment of 1.0 mm.
Analysis of CT images was performed as described
previously. A statistical analysis of the results was not performed since the number of animals included in this study
did not support a statistical approach.
After removal of the autoinjectors from the injection site,
the postinjection exposed needle lengths were determined
using CT imaging. The postinjection needle scans were loaded
into Analyze (Analyze 7.0 Software Suites, AnalyzeDirect,
Inc., Overland Park, KS, USA), and the threshold was adjusted
so that only the needle and plastic housing were visible. For
each article, the tip of the needle was chosen as the start point
and the base of the needle proximal to the plastic housing was
chosen as the end point when measuring.
Animals were euthanized as described previously. The
pig carcasses were returned to the necropsy room and the skin
directly over the injection site was incised with a scalpel, and
the depth of the combined skin/fat layer was measured using
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digital calipers. The skin/fat layer was quantified to determine
that the depth of tissue was consistent and to ensure that the
extended needles of the autoinjectors were long enough to
reach the muscle tissue underlying the fat layer.

Results
Study 1: autoinjector versus syringe

Injection using both autoinjectors (20 Ga ×0.8 in and
22 Ga ×0.6 in) resulted in larger peak dispersion volumes
(8,677 and 7,049 mm3, respectively) than injections using
the manual syringes (6,917 mm3 for the 0.8 in syringe and
6,521 mm3 for the 0.6 in syringe), as shown in Figure 1. In
addition, use of devices (autoinjector or syringe) with 20
Ga ×0.8 in needles (P2) resulted in larger dispersion volumes
than use of devices with 22 Ga ×0.6 in needles (P1) (Figure 1),
suggesting that needle gauge and/or length affected injectate
delivery. Autoinjection with the 20 Ga ×0.8 in needle gave
both the highest peak dispersion volume (8,677 mm3; Figure
1) and greatest uptake (29% peak volume remaining in the
tissue at 60 minutes; Figure 2) of the four injection groups
studied.
Additionally, both autoinjectors showed more rapid and
complete uptake of the injectate within the 60-minute period
studied compared to the syringes, as evidenced by the percentage of peak volume remaining in the muscle tissue at
60 minutes (Figure 2: 30% for the 20 Ga ×0.8 in autoinjector
versus 87% for the 20 Ga ×0.8 in syringe and 71% for the
22 Ga ×0.6 in autoinjector versus 83% for the 22 Ga ×0.6 in
syringe). The average rate of uptake at the 60-minute time
point for the 20 Ga ×0.8 in autoinjector and the 22 Ga ×0.6 in
autoinjector was 111.5 and 38.1 mm3/min, respectively, as
compared to 15.8 and 14.0 mm3/min for the 20 Ga ×0.8 in
syringe and 22 Ga ×0.6 in syringe, respectively.
Across the four injection devices (autoinjector and
syringe, each with two needle types), there was a positive
relationship between peak dispersion volume and percentage
uptake, as indicated by the percentage reduction in dispersion
volume from peak to 60 minutes (Figure 3).

Study 2: autoinjectors with different
mechanical properties
The postinjection exposed needle lengths were determined
by CT analysis for all autoinjectors in this study. EpiPen
exposed needle lengths ranged from 0.59 to 0.62 in (15.0–
15.7 mm). Twinject 0.30 mL exposed needle lengths ranged
from 0.48 to 0.50 in (12.2–12.7 mm). EpiPen Jr exposed
needle lengths ranged from 0.56 to 0.58 in (14.2–14.7 mm).
Twinject 0.15 mL exposed needle lengths ranged from 0.47
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Autoinjector 22 Ga × 0.6 in
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Syringe 22 Ga × 0.6 in
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Figure 1 Injectate dispersion volume of diazepam autoinjectors and syringes (Study 1).
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Figure 2 Percentage dispersion of injectate at 60 minutes (Study 1).

262

There were differences in tissue dispersion volume
among the autoinjectors tested. Study group P1 compared
Anapen and EpiPen, both delivering 0.3 mL injectate.
The initial dispersion volume was greater for EpiPen
(949.76 mm3) than for Anapen (576.70 mm 3), and the
injectate reached its peak dispersion volume in a shorter
time for EpiPen (1 minute) than for Anapen (9 minutes). In
addition, there was greater uptake of the injectate from the
site of injection 15 minutes postinjection for EpiPen (80%)
than for Anapen (,5%).
Study group P3 compared Twinject 0.3 mL and EpiPen,
both delivering 0.3 mL injectate. The EpiPen had a greater
initial injectate dispersion volume (791.94 mm3) than did
Twinject 0.3 mL (721.18 mm3). There was greater uptake
100

in

Dispersion of injectate
at 60 min (%)

to 0.52 in (11.9–13.2 mm). Anapen exposed needle lengths
ranged from 0.29 to 0.33 in (7.4–8.4 mm).
The postmortem measurement of the combined depth of
the skin/fat layer directly under the autoinjection site demonstrated a similar measured depth of skin/fat layer in the
left thigh and right thigh across all animals in all groups (P1,
P2, and P3) of 2.18±0.51 mm (mean ± standard deviation)
(0.086±0.02 in) and 2.31±0.36 mm (0.09±0.01 in), respectively (Table 3). The average depth of the skin/fat layer was
2.24±0.44 mm (0.09±0.02 in).

Syringe 20 Ga × 0.8 in
Syringe 22 Ga × 0.6 in

60

Autoinjector 20 Ga × 0.8 in
Autoinjector 22 Ga × 0.6 in

40

y=0.0003x−1.6015 R2=0.941

20
0
6,000

7,000

8,000

9,000

10,000

Peak dispersion volume (mm3)
Figure 3 Percentage uptake versus peak dispersion volume (Study 1).
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Table 3 Study 2: injection site skin fat layer measurements
Study comparison
and animal
Study group P1
Animal 1
Animal 2
Animal 3
Animal 4
Mean ± SD
Study group P2
Animal 1
Animal 2
Animal 3
Animal 4
Mean ± SD
Study group P3
Animal 1
Animal 2
Animal 3
Animal 4

Autoinjector applied
to left thigh (Ga × in)

Autoinjector applied
to right thigh (Ga × in)

Measured skin/fat depth (mm [in])
Left thigh (EpiPen®)

Right thigh (test injector)

Anapen®
27×0.3
Anapen
27×0.3
Anapen
27×0.3
Anapen
27×0.3

EpiPen
22×0.6
EpiPen
22×0.6
EpiPen
22×0.6
EpiPen
22×0.6

1.86 (0.07)

2.41 (0.10)

1.65 (0.07)

2.04 (0.08)

1.80 (0.07)

1.91 (0.08)

2.64 (0.10)

2.38 (0.09)

1.99±0.44 (0.08±0.02)

2.19±0.25 (0.09±0.01)

2.01 (0.08)

1.93 (0.08)

2.18 (0.09)

2.51 (0.10)

2.24 (0.09)

2.22 (0.09)

3.57 (0.14)

2.37 (0.09)

2.50±0.72

2.26±0.25

1.91 (0.08)

3.27 (0.13)

2.09 (0.08)

2.00 (0.08)

1.93 (0.08)

2.28 (0.09)

2.26 (0.09)

2.35 (0.09)

2.05±0.16

2.48±0.55

Twinject®
25×0.5
Twinject
25×0.5
Twinject
25×0.5
Twinject
25×0.5

Twinject
25×0.5
Twinject
25×0.5
Twinject
25×0.5
Twinject
25×0.5

EpiPen® Jr
22×0.5
EpiPen Jr
22×0.5
EpiPen Jr
22×0.5
EpiPen Jr
22×0.5

EpiPen
22×0.6
EpiPen
22×0.6
EpiPen
22×0.6
EpiPen
22×0.6

Mean ± SD
Abbreviation: SD, standard deviation.

of the injectate 15 minutes postinjection for EpiPen (97%)
than for Twinject 0.3 mL (,5%).
Study group P2 compared Twinject delivering 0.15 mL
and EpiPen Jr delivering 0.3 mL. EpiPen Jr had a greater
peak injectate dispersion volume (934.77 mm3) than Twinject
0.15 mL (412.04 mm3). It was noted that the EpiPen Jr 0.3 mL
injects twice the volume of injectate than the Twinject
0.15 mL. To obtain a more effective interpretation of the difference in dispersion between the two devices, the data was
normalized by dividing the dispersion volume by the injectate
volume (Figure 4), resulting in a dispersion ratio (average
measured dispersion volume/target injectate volume). Of the
three test devices evaluated in this study (Anapen, EpiPen,
and Twinject) the Anapen had the lowest initial dispersion
ratio of 1.9. Twinject 0.15 mL had a higher initial dispersion
ratio than Twinject 0.3 mL (2.7 versus 2.4), both of which
were higher than Anapen. The EpiPen autoinjectors achieved
higher initial dispersion ratios (range: 2.6–3.2) than Anapen
and higher than or similar dispersion ratios to Twinject.
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A notable difference between EpiPen and the other two
autoinjectors was the decrease in dispersion volume over
the 15-minute testing period. For EpiPen autoinjectors, the
dispersion ratio was ,30% of the initial value by 15 minutes,
suggesting substantial uptake of injectate, whereas the dispersion ratio for Anapen and Twinject remained relatively
constant, at .95% of the initial value by 15 minutes, suggesting negligible uptake (Figure 4).

Discussion
Our investigations demonstrated that the functional characteristics of IM delivery systems influence dispersion and
uptake of the injected material. In the first study, there was
a clear difference between the autoinjector and the manual
syringe with regard to characteristics of the injectate within
the tissue. The greater dispersion volume of injectate for the
autoinjectors, representing a wider tissue contact, is likely
due to the greater force of injection provided by the spring
within the autoinjector compared to that anticipated for
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Mean dispersion volume/target injectate volume
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Twinject 0.3 mL (P3)
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Figure 4 Dispersion volume/target injectate volume ratio over time for autoinjectors (Study 2).

manual injection with a syringe. The autoinjector used in the
first study has a spring force of ∼23 lbs (Table 2), whereas
a comparable design parameter for manual strength when
using a syringe to give an injection, sustained thumb–finger
grip strength, is 6.4–8 lbs for the 5th percentile of males.19
The results also provide evidence that needle gauge and/or
length affect injectate dispersion, since for both the manual
syringe and the autoinjector, the 20 Ga ×0.8 in needle
produced a greater dispersion volume of injectate than for
devices with the 22 Ga ×0.6 in needle. This relationship
could be a result of greater speed of delivery through the
larger diameter (lower gauge) or the deeper injection depth
of the 0.8 in needle.
The results of Study 1 also suggest that the greater dispersion provided by the autoinjector delivery systems correlates
with greater uptake of the injected material. The positive
relationship shown between peak dispersion volume and
percentage uptake across the four injection devices (autoinjector and syringe, each with two needle types) could be
because with a larger dispersion volume, the injectate comes
into greater contact with the vascular bed, leading to more
rapid absorption of material.
The results of Study 2 confirmed and extended those of
Study 1. In particular, there were substantial differences
in the dispersion and uptake of injectate among autoinjectors that differed with regard to spring force (ie, speed and
pressure of delivery), needle gauge, needle length, injection
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volume, and resulting dispense time. The most noteworthy difference in injectate parameters was between the
EpiPen autoinjectors and the two other brands, Anapen and
Twinject. The EpiPen resulted in greater dispersion volume, and substantially greater uptake at the 15-minute
postinjection time point than either Anapen or Twinject.
Since the most substantial functional difference between
EpiPen and the other autoinjectors is the spring force
which drives the injection18 (23 lbs for EpiPen compared
to 6 lbs for Twinject and 2.1 lbs for Anapen; Table 2),
this factor is most likely responsible for the difference
in dispersion and uptake of injectate. The lower gauge
(larger needle diameter) of the EpiPen needle may also
have contributed to the differences among autoinjectors,
since this parameter affects injectate dispersion volume,
as observed in Study 1.
One characteristic of the autoinjectors which could have
contributed to a difference in dispersion volume is extended
needle length. If any of the autoinjectors had an extended
needle length that was not sufficient to reach the muscle layer,
this could have produced a significant decrease in the average
dispersion volume for that type of autoinjector. However, the
results demonstrate that this was not a factor in this study,
since the shortest postinjection needle length was 7.4 mm
and the thickest skin/fat layer was 2.68 mm. Thus, all of
the needles penetrated well beyond the skin and fat, and the
autoinjections were given into muscle in all animals.
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It is worth emphasizing that the greatest difference
between EpiPen and the other autoinjectors was the percentage uptake of injectate. This is the measure most likely to
correlate to drug serum concentration, which is a key contributor to the effectiveness of the treatment.
Adrenaline administration by autoinjector is viewed as the
most effective first-line treatment for the management of anaphylaxis in the community. Autoinjectors provide fixed dosing,
consistent needle penetration and depth, and can be administered quickly with a consistent dispersion pattern, which are
important attributes in an anaphylaxis emergency. It is more
difficult for patients and caregivers to achieve accurate and
timely IM self-administration of adrenaline using an ampoule,
needle, and syringe. The use of autoinjectors is associated
with a higher cost in a health-care setting, whereas a manual
syringe and needle may offer a more cost-effective treatment.
However, the force of injection and needle depth associated
with syringe and needle use may be more variable.
The limitations of this study include the small number of
animals tested in each device group. Furthermore, injections
into subcutaneous tissue were not part of this study, so the
dispersion characteristics described apply only to injections
into muscle tissue. Given the robust nature of the results,
however, it is likely that the conclusions accurately reflect
the relationship between functional aspects of drug delivery
devices and the dispersion volume and uptake of injectate.
Also, because individual functional aspects of the devices
were not tested in isolation, any one aspect (eg, spring force)
cannot definitely be attributed to a difference in dispersion
volume or uptake. Although an understanding of the relationship between functional aspects of the devices and the
force and speed of injectate delivery provides a reasonable
basis for interpreting what led to differences among devices,
additional studies are required to confirm the conclusions
presented here. At the time of this study, the Anapen was
not available in the US, but has been available in Europe
since 2003. The Twinject autoinjector used in Study 2 has
been withdrawn from the market since the completion of this
study, and replaced with a similar device called Adrenaclick.
There have been no functional changes affecting the design
of EpiPen since this study was conducted that would affect
the results seen in this study. The EpiPen design used in this
study is the one that is currently commercially available.

Conclusion
This study demonstrated the effective use of an animal
model and an imaging methodology to assess the impact of
specific functional properties of injection devices on discrete
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parameters of an IM injection. Uptake of injected material,
which is likely to contribute significantly to serum levels and
effectiveness of a drug, was greatest under circumstances in
which the force of injection was highest. This was true among
different autoinjector types and when comparing autoinjector
delivery to injection by a manual syringe. Needle size including gauge and length contributed to a lesser extent, with lower
gauge (larger diameter needle) resulting in greater dispersion and uptake. These results may be used to guide further
improvements to the performance of injection technologies.

Acknowledgments
This work was carried out at Georgetown University,
Washington, DC, USA, and was funded by Meridian Medical
Technologies, Inc., Maryland, USA, a Pfizer company.
Editorial support was provided by Gayle Scott and Sharmila
Blows of Engage Scientific Solutions and funded by Pfizer.
The authors would like to thank Megha Mahadevan and Mike
Mesa for providing assistance with these studies.

Disclosure
Authors Robert L Hill, John G Wilmot, and Rajesh B Shukla
were employees of Meridian Medical Technologies, Inc.
during the conduct of this study and preparation of the
manuscript. The authors report no other conflicts of interest
in this work.

References

1. Shearer P, Riviello J. Generalized convulsive status epilepticus in adults
and children: treatment guidelines and protocols. Emerg Med Clin North
Am. 2011;29(1):51–64.
2. Wagner CW. Anaphylaxis in the pediatric patient: optimizing management and prevention. J Pediatr Health Care. 2013;27(2 Suppl):S5–S17;
quiz S18–S19.
3. Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current
issues. Curr Opin Allergy Clin Immunol. 2010;10(4):354–361.
4. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant
therapy for status epilepticus. Cochrane Database Syst Rev.
2005;(4):CD003723.
5. Pellock JM, Marmarou A, DeLorenzo R. Time to treatment in prolonged
seizure episodes. Epilepsy Behav. 2004;5(2):192–196.
6. Lagae L. Clinical practice: the treatment of acute convulsive seizures
in children. Eur J Pediatr. 2011;170(4):413–418.
7. O’Dell C, O’Hara K. School nurses’ experience with administration of
rectal diazepam gel for seizures. J Sch Nurs. 2007;23(3):166–169.
8. Bhattacharyya M, Kalra V, Gulati S. Intranasal midazolam vs rectal
diazepam in acute childhood seizures. Pediatr Neurol. 2006;34(5):
355–359.
9. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus
intravenous therapy for prehospital status epilepticus. N Engl J Med.
2012;366(7):591–600.
10. Garnett WR, Barr WH, Edinboro LE, Karnes HT, Mesa M, Wannarka GL.
Diazepam autoinjector intramuscular delivery system versus diazepam rectal gel: a pharmacokinetic comparison. Epilepsy Res.
2011;93(1):11–16.

submit your manuscript | www.dovepress.com

Dovepress

265

Dovepress

Hill et al
11. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults:
intramuscular versus subcutaneous injection. J Allergy Clin Immunol.
2001;108(5):871–873.
12. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption
in children with a history of anaphylaxis. J Allergy Clin Immunol.
1998;101(1 Pt 1):33–37.
13. Wu PI, Minisini S, Edelman ER. Intramuscular drug transport under
mechanical loading: resonance between tissue function and uptake. J
Control Release. 2009;136(2):99–109.
14. Overcashier DE, Chan EK, Hsu CC. Technical considerations in the
development of prefilled syringes for protein products. Am Pharm Rev.
2006;9(7):77–83.
15. Abou-Khalil B, Wheless J, Rogin J, et al. A double-blind, randomized,
placebo-controlled trial of a diazepam auto-injector administered by
caregivers to patients with epilepsy who require intermittent intervention
for acute repetitive seizures. Epilepsia. 2013;54(11):1968–1976.

16. US Food and Drug Administration. CFR Code of Federal Regulations
Title 21. Good Laboratory Practice for Nonclinical Laboratory Studies. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/
cfcfr/cfrsearch.cfm?cfrpart=58. Accessed May 10, 2013.
17. Al-amri SS, Kalyankar NV, Khamitkar SD. Image segmentation by
using threshold techniques. J Computing. 2010;2(5):83–86.
18. Wilmot JG, Shukla RB, Mahadevan L. US Patent Application
2012/0101475 A1. Meridian Medical Technologies, Inc., Columbia,
MD (US) 12/909, 070 October 21, 2010.
19. Department of Defense Human Factors Engineering Technical Advisory
Group. Human Engineering Design Data Digest. Washington, DC: US
Government Printing Office; 2000. Available from: http://www.dtic.mil/
cgi-bin/GetTRDoc?AD=ADA467401. Accessed November 10, 2015.

Dovepress

Medical Devices: Evidence and Research

Publish your work in this journal
Medical Devices: Evidence and Research is an international, peerreviewed, open access journal that focuses on the evidence, technology,
research, and expert opinion supporting the use and application of
medical devices in the diagnosis, treatment and management of clinical conditions and physiological processes. The identification of novel

devices and optimal use of existing devices which will lead to improved
clinical outcomes and more effective patient management and safety is
a key feature. The manuscript management system is completely online
and includes a quick and fair peer-review system. Visit http://www.
dovepress.com/testimonials.php to read real quotes from authors.

Submit your manuscript here: http://www.dovepress.com/medical-devices-evidence-and-research-journal

266

submit your manuscript | www.dovepress.com

Dovepress

Medical Devices: Evidence and Research 2016:9

